The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance-Reference-Cited by-同舟云学术

The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance

Published:2003-11-17 Issue:24 Volume:100 Page:13881-13886
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Rawat R.,Whitty A.,Tonge P. J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. Tuberculosis: Commentary on a Reemergent Killer

2. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study

3. Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance

4. Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives

5. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trehalose catalytic shift is an intrinsic factor in Mycobacterium tuberculosis that enhances phenotypic heterogeneity and multidrug resistance;2024-09-13

2. Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models;International Journal of Molecular Sciences;2024-06-28

3. Machine learning assisted methods for the identification of low toxicity inhibitors of Enoyl-Acyl Carrier Protein Reductase (InhA);Computational Biology and Chemistry;2024-06

4. The mechanisms and clinical potential of collateral sensitivity in Mycobacterium tuberculosis: A literature review;The Microbe;2024-06

5. An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis;Proceedings of the National Academy of Sciences;2024-05